Pancreatic Cancer Research

ResearcherKobe University HospitalActive in the last 2 years

Ryohei Sasaki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4994-9386; OpenAlex author ID A5027718340. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
18
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: 2 papers · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 2 papers

Papers 10

  1. Radiation suppresses liver metastases via exosome secretion in pancreatic cancer cells. Last author DOI 10.1038/s41598-025-08826-1↗
  2. Catalase-Knockout Complements the Radio-Sensitization Effect of Titanium Peroxide Nanoparticles on Pancreatic Cancer Cells. Co-author DOI 10.3390/molecules30030629↗
  3. Ultrasound-stimulated Microbubbles for Treatment of Pancreatic Cancer Cells with Radiation and Nanoparticles: In vitro Study. Last author DOI 10.4103/jmp.jmp_30_24↗
  4. Reactive oxygen species-inducing titanium peroxide nanoparticles as promising radiosensitizers for eliminating pancreatic cancer stem cells. Last author DOI 10.1186/s13046-022-02358-6↗
  5. Efficacy of Spacers in Radiation Therapy for Locally Advanced Pancreatic Cancer: A Planning Study. Last author DOI 10.21873/anticanres.14801↗
  6. Gold Nanoparticle-Incorporated Molecularly Imprinted Microgels as Radiation Sensitizers in Pancreatic Cancer. Co-author DOI 10.1021/acsabm.8b00766↗
  7. Titanium peroxide nanoparticles enhanced cytotoxic effects of X-ray irradiation against pancreatic cancer model through reactive oxygen species generation in v… First author DOI 10.1186/s13014-016-0666-y↗
  8. MGDG extracted from spinach enhances the cytotoxicity of radiation in pancreatic cancer cells. Last author DOI 10.1186/s13014-016-0729-0↗
  9. Monogalactosyl diacylglycerol, a replicative DNA polymerase inhibitor, from spinach enhances the anti-cell proliferation effect of gemcitabine in human pancrea… First author DOI 10.1016/j.bbagen.2012.11.004↗
  10. A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis. Co-author DOI 10.1016/j.radonc.2011.12.029↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hiroaki Akasaka · 8 shared papers, 2013–2025 · strength 0.96
  2. Chiaki Ogino · 3 shared papers, 2016–2025 · strength 0.46
  3. Mohammed Salah · 2 shared papers, 2022–2025 · strength 0.35
  4. Masao Nakayama · 3 shared papers, 2016–2024 · strength 0.35
  5. Winda Tasia · 1 shared paper, 2025 · strength 0.27
  6. Hiroki Kawaguchi · 2 shared papers, 2021–2022 · strength 0.27
  7. Ai Nakaoka · 1 shared paper, 2025 · strength 0.20
  8. Makoto Shinoto · 1 shared paper, 2021 · strength 0.12
  9. Yoshiyuki Shioyama · 1 shared paper, 2021 · strength 0.12
  10. Takumi Fukumoto · 1 shared paper, 2021 · strength 0.12
  11. Aoi Yoshida · 1 shared paper, 2019 · strength 0.11
  12. Toshifumi Takeuchi · 1 shared paper, 2019 · strength 0.11
  13. Yoshiyuki Mizushina · 2 shared papers, 2013–2016 · strength 0.10
  14. Akihiko Kondo · 1 shared paper, 2016 · strength 0.05
  15. Kento Takatori · 1 shared paper, 2012 · strength 0.03
  16. Masao Murakami · 1 shared paper, 2012 · strength 0.03
  17. Yonson Ku · 1 shared paper, 2012 · strength 0.03
  18. Kazuki Terashima · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.